These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9413274)
1. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. de la Concha EG; Arroyo R; Crusius JB; Campillo JA; Martin C; Varela de Seijas E; Peña AS; Clavería LE; Fernandez-Arquero M J Neuroimmunol; 1997 Dec; 80(1-2):172-8. PubMed ID: 9413274 [TBL] [Abstract][Full Text] [Related]
2. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis. McDonnell GV; Mawhinney H; Graham CA; Hawkins SA; Middleton D J Neurol Sci; 1999 May; 165(1):77-83. PubMed ID: 10426152 [TBL] [Abstract][Full Text] [Related]
3. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population. Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364 [TBL] [Abstract][Full Text] [Related]
4. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome. Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585 [TBL] [Abstract][Full Text] [Related]
5. The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis. Greer JM; Pender MP J Neurol Neurosurg Psychiatry; 2005 May; 76(5):656-62. PubMed ID: 15834022 [TBL] [Abstract][Full Text] [Related]
6. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164 [TBL] [Abstract][Full Text] [Related]
7. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population. Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T Eur J Neurol; 2011 Feb; 18(2):337-342. PubMed ID: 20629714 [TBL] [Abstract][Full Text] [Related]
8. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel. Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697 [TBL] [Abstract][Full Text] [Related]
9. Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Fukazawa T; Yamasaki K; Ito H; Kikuchi S; Minohara M; Horiuchi I; Tsukishima E; Sasaki H; Hamada T; Nishimura Y; Tashiro K; Kira J Tissue Antigens; 2000 Mar; 55(3):199-205. PubMed ID: 10777094 [TBL] [Abstract][Full Text] [Related]
10. HLA class II polymorphism in Latin American patients with multiple sclerosis. Rojas OL; Rojas-Villarraga A; Cruz-Tapias P; Sánchez JL; Suárez-Escudero JC; Patarroyo MA; Anaya JM Autoimmun Rev; 2010 Apr; 9(6):407-13. PubMed ID: 19896562 [TBL] [Abstract][Full Text] [Related]
11. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DR beta 1 chain in multiple sclerosis. Ghabanbasani MZ; Gu XX; Spaepen M; Vandevyver C; Raus J; Marynen P; Carton H; Cassiman JJ J Neuroimmunol; 1995 Jun; 59(1-2):77-82. PubMed ID: 7797622 [TBL] [Abstract][Full Text] [Related]
12. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study. Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J; J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848 [TBL] [Abstract][Full Text] [Related]
13. Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. de Jong BA; Huizinga TW; Bollen EL; Uitdehaag BM; Bosma GP; van Buchem MA; Remarque EJ; Burgmans AC; Kalkers NF; Polman CH; Westendorp RG J Neuroimmunol; 2002 May; 126(1-2):172-9. PubMed ID: 12020968 [TBL] [Abstract][Full Text] [Related]
14. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis. Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892 [TBL] [Abstract][Full Text] [Related]
15. TAP2 polymorphisms in Australian multiple sclerosis patients. Bennetts BH; Teutsch SM; Heard RN; Dunckley H; Stewart GJ J Neuroimmunol; 1995 Jun; 59(1-2):113-21. PubMed ID: 7797612 [TBL] [Abstract][Full Text] [Related]
16. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis. Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T J Neurol Sci; 2010 Nov; 298(1-2):96-100. PubMed ID: 20810130 [TBL] [Abstract][Full Text] [Related]
17. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status. Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835 [TBL] [Abstract][Full Text] [Related]
18. Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies. Zhang Q; Lin CY; Dong Q; Wang J; Wang W Autoimmun Rev; 2011 Jun; 10(8):474-81. PubMed ID: 21440682 [TBL] [Abstract][Full Text] [Related]
19. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran. Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442 [TBL] [Abstract][Full Text] [Related]
20. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients. Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]